Passage - Fingolimod

Investigator: Eddie Patton, MD

Study Coordinator: Sheila Moore

Status: Enrolling Number: NCT01442194

Phone: 713.441.3250

IRB Number: Pro00011449


The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further explore the incidence of selected safety- related outcomes and to further monitor the overall safety profile of fingolimod under conditions of routine medical practice.
More to Explore